Screening compound: C21H19ClFN3O4 (S338-1109)

Screening compound: C<sub>21</sub>H<sub>19</sub>ClFN<sub>3</sub>O<sub>4</sub> (S338-1109)
Screening compound: C<sub>21</sub>H<sub>19</sub>ClFN<sub>3</sub>O<sub>4</sub> (S338-1109) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C21H19ClFN3O4 (S338-1109)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S338-1109

Molecular Formula

C21H19ClFN3O4 (C21 H19 ClFN3 O4)

Compound Name

(2-CHLORO-5-FLUOROPHENYL){(2S)-2-[3-(3,4-DIMETHOXYPHENYL)-1,2,4-OXADIAZOL-5-YL]TETRAHYDRO-1H-PYRROL-1-YL}METHANONE

IUPAC name

5-[(2S)-1-(2-chloro-5-fluorobenzoyl)pyrrolidin-2-yl]-3-(34-dimethoxyphenyl)-124-oxadiazole

SMILES

COc(ccc(-c1noc([C@H](CCC2)N2C(c(cc(cc2)F)c2Cl)=O)n1)c1)c1OC

InChI

InChI=1S/C21H19ClFN3O4/c1-28-17-8-5-12(10-18(17)29-2)19-24-20(30-25-19)16-4-3-9-26(16)21(27)14-11-13(23)6-7-15(14)22/h5-8,10-11,16H,3-4,9H2,1-2H3/t16-/m0/s1

InChI Key

OEDAXMBFQDRSBU-INIZCTEOSA-N

MDL Number (MFCD)

C21H19ClFN3O4 (S338-1109) in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Ligand-Gated Ion Channels Library (3887 compounds)

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

MEF2-HDAC (class II) Modulators Library (5147 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Eye
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Cancer
  • Cancer
  • Musculoskeletal
  • Female
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Ion Channels
  • Proteases
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • Epigenetic
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with C21H19ClFN3O4 (S338-1109) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C21H19ClFN3O4 (S338-1109)?
Check Price and Availability of C21H19ClFN3O4 (S338-1109), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C21H19ClFN3O4 (S338-1109) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C21H19ClFN3O4 (S338-1109)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C21H19ClFN3O4 (S338-1109)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C21H19ClFN3O4 (S338-1109) available by request